Dalcinonacog alfa

N/A

Report date: 2025/04/30 20:00:42

Base Information

Drug NameDalcinonacog alfa
Drug Alias NameDalcA凝血因子IX生物仿制药CB-FIX凝血因子IX生物类似药FIX-NG +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factorBiologics > Biosimilar
Mechanisms of ActionCoagulation factor IX replacements
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth AfricaSouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCatalyst Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIsu Abxis Co LtdGC Biopharma CorpCatalyst Biosciences Inc
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A